Telitacicept is a dual-targeting agent that attaches to and blocks the effects of 2 key signaling proteins, B-lymphocyte ...

On June 16, 2025, RemeGen Co., Ltd. ('RemeGen', stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand ...

Find more information on the Altmetric Attention Score and how the score is calculated. The α7 nicotinic acetylcholine receptor (nAChR) is a recognized drug target for dementias of aging and certain ...

Following insulin injection, a series of proteins were recognized by an anti-phosphotyrosine antibody (αP42-2) raised against the residue most frequently ... we identified 16 proteins classified as (1 ...

Dihydroergotamine (DHE) is an older drug used for migraine relief. Learn about new formulations and find out if you're a good candidate for this powerful treatment.